C07K 2317/21
From primates
Official title: from primates, e.g. man
C07K2317/21 (From primates) appears on 6,515 US grants and 11,964 published applications in this corpus.
Search patents in C07K- Granted patents
- 6,515
- Published applications
- 11,964
- Assignees
- 2,617
- Inventors
- 16,025
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 8 | 0 |
| 1998 | 18 | 0 |
| 1999 | 27 | 0 |
| 2000 | 18 | 0 |
| 2001 | 20 | 8 |
| 2002 | 25 | 67 |
| 2003 | 25 | 158 |
| 2004 | 27 | 158 |
| 2005 | 27 | 179 |
| 2006 | 56 | 190 |
| 2007 | 60 | 199 |
| 2008 | 96 | 220 |
| 2009 | 138 | 342 |
| 2010 | 180 | 354 |
| 2011 | 178 | 370 |
| 2012 | 257 | 413 |
| 2013 | 251 | 440 |
| 2014 | 296 | 542 |
| 2015 | 359 | 594 |
| 2016 | 431 | 751 |
| 2017 | 409 | 765 |
| 2018 | 442 | 677 |
| 2019 | 444 | 761 |
| 2020 | 456 | 719 |
| 2021 | 469 | 824 |
| 2022 | 405 | 745 |
| 2023 | 343 | 667 |
| 2024 | 408 | 801 |
| 2025 | 403 | 569 |
| 2026 | 234 | 451 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Enhancement of immune response with oral immunoglobulin polypeptides6 Oct 2026US 12,752,004 B2Iogenetics, LLC
- Means for specifically eliminating perilipin-1 fragment presenting adipocytes29 Sep 2026US 12,747,286 B2Alytas Therapeutics GmbH
- Anti-Sortilin antibodies and use thereof29 Sep 2026US 12,747,294 B2H. Lundbeck A.S.
- Anti-CCR8 antibodies for treating cancer29 Sep 2026US 12,747,296 B2Bristol-Myers Squibb Company
- Multi-specific antibodies binding to BCMA29 Sep 2026US 12,747,298 B2TeneoBio, Inc.
- Methods for treating or preventing asthma by administering an il-4r antagonist8 Oct 2026US 2026/0306627 A1Regeneron Pharmaceuticals, Inc.
- Radiolabeled met binding proteins for immuno-pet imaging8 Oct 2026US 2026/0306682 A1Regeneron Pharmaceuticals, Inc.
- Pharmaceutical Composition for Treating or Preventing Cancer8 Oct 2026US 2026/0308239 A1I.S.M., Inc.
- Methods of treating inflammatory diseases8 Oct 2026US 2026/0308246 A1Boehringer Ingelheim International GmbH
- Selective reduction of cysteine residues in il-17 antibodies8 Oct 2026US 2026/0308247 A1Novartis AG
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,541US 5,661,016 AGenPharm International, Inc. · 1997